Robert Canarick - 21 May 2025 Form 4 Insider Report for INTEGRATED BIOPHARMA INC (INBP)

Role
Director
Signature
/s/ Robert Canarick
Issuer symbol
INBP
Transactions as of
21 May 2025
Net transactions value
+$15,750
Form type
4
Filing time
22 May 2025, 17:09:20 UTC
Previous filing
08 Aug 2024
Next filing
20 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Canarick Robert Director C/O INTEGRATED BIOPHARMA, INC., 201 ROUTE 22, HILLSIDE /s/ Robert Canarick 22 May 2025 0001382218

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INBP Common Stock Award $15,750 +175,000 +295% $0.0900 234,233 21 May 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INBP Stock Option (Right to Buy) Disposed to Issuer $0 -175,000 -100% $0.000000 0 21 May 2025 Common Stock 175,000 $0.0900 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 175,000 common stock shares acquired upon exercise of stock option grant dated June 2, 2015.
F2 75% of the options became exercisable on June 2, 2015 with 25% becoming exercisable in twelve (12) equal monthly installments beginning on July 2, 2015.